Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has announced the quotation of nearly 2.9 million fully paid ordinary securities on the ASX, effective October 16, 2024. This move is part of a previously disclosed transaction, signaling potential growth opportunities for investors. The new securities are expected to attract attention in the financial markets.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.